These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1281 related items for PubMed ID: 9489619

  • 1. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 2. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F, Schmidt K, Nielsen EB, Mayer B.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL, Wu CC, Teng CM.
    Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
    [Abstract] [Full Text] [Related]

  • 6. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
    Bawankule DU, Sathishkumar K, Sardar KK, Chanda D, Krishna AV, Prakash VR, Mishra SK.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
    [Abstract] [Full Text] [Related]

  • 7. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J, Zabel U, Hübner U, Hatzelmann A, Wagner B, Wanner C, Schmidt HH.
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [Abstract] [Full Text] [Related]

  • 8. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
    Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B.
    Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
    [Abstract] [Full Text] [Related]

  • 9. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW, Gath I, Förstermann U, Nawrath H.
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [Abstract] [Full Text] [Related]

  • 10. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
    Schrammel A, Behrends S, Schmidt K, Koesling D, Mayer B.
    Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
    [Abstract] [Full Text] [Related]

  • 11. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
    Göçmen C, Büyüknacar HS, Kots AY, Murad F, Kiroglu O, Kumcu EK.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
    [Abstract] [Full Text] [Related]

  • 12. Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.
    Schindler U, Strobel H, Schönafinger K, Linz W, Löhn M, Martorana PA, Rütten H, Schindler PW, Busch AE, Sohn M, Töpfer A, Pistorius A, Jannek C, Mülsch A.
    Mol Pharmacol; 2006 Apr; 69(4):1260-8. PubMed ID: 16332991
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC, Challiss RA, Boyle JP.
    Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
    [Abstract] [Full Text] [Related]

  • 14. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
    Ding KH, Abdel-Latif AA.
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
    [Abstract] [Full Text] [Related]

  • 15. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS, Marks GS, Brien JF, Nakatsu K.
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [Abstract] [Full Text] [Related]

  • 16. Blockade of nitrergic neuroeffector transmission in guinea-pig colon by a selective inhibitor of soluble guanylyl cyclase.
    Olgart C, Hallén K, Wiklund NP, Iversen HH, Gustafsson LE.
    Acta Physiol Scand; 1998 Jan; 162(1):89-95. PubMed ID: 9492906
    [Abstract] [Full Text] [Related]

  • 17. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.
    Kalsi JS, Rees RW, Hobbs AJ, Royle M, Kell PD, Ralph DJ, Moncada S, Cellek S.
    J Urol; 2003 Feb; 169(2):761-6. PubMed ID: 12544359
    [Abstract] [Full Text] [Related]

  • 18. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
    Li L, Vaali K, Paakkari I, Vapaatalo H.
    Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
    [Abstract] [Full Text] [Related]

  • 19. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P, Boucher JL, Schott C, Beranova P, Chalupsky K, Callizot N, Muller B, Entlicher G, Mansuy D, Stoclet JC.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [Abstract] [Full Text] [Related]

  • 20. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
    Rautureau Y, Gowers I, Wheeler-Jones CP, Baxter GF.
    Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 65.